MY CLINIC
The cost of PRP/PRGF ovarian rejuvenation in the Czech Republic typically ranges from $2,800 to $4,200. Prices vary depending on the clinic, the doctor’s experience, and whether you opt for PRP or PRGF technology. In the United States, the average cost is $9,800 (per ASRM). This means PRP/PRGF ovarian rejuvenation in the Czech Republic is about 64% less expensive than in the U.S.
Czech clinics usually include the initial consultation, pre-op blood tests, post-op medication, follow-up visits, and 24/7 English-speaking support. You also receive a personalized treatment plan and post-op care instructions. In the U.S., costs often cover only the procedure itself, with consultations, tests, and aftercare billed separately. Always confirm what’s included before booking.
Why choose the Czech Republic for PRP/PRGF ovarian rejuvenation?
Access advanced PRP/PRGF ovarian rejuvenation solutions in trusted clinics .
| Czech Republic | Turkey | Austria | |
| PRP/PRGF ovarian rejuvenation | from $2,800 | from $4,410 | from $3,000 |
No hidden fees – just official clinic prices. Pay at the clinic for PRP/PRGF ovarian rejuvenation upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in PRP/PRGF ovarian rejuvenation and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your PRP/PRGF ovarian rejuvenation journey.
PRP or PRGF ovarian rejuvenation in the Czech Republic is an experimental fertility treatment using autologous plasma injections to stimulate ovarian function. Clinics in Prague use this technique for women with premature ovarian insufficiency or diminished reserves to improve egg quality before IVF cycles.
Bookimed Expert Insight: Czech fertility centers like MY CLINIC often link with academic institutions like Charles University to offer these emerging therapies. While costs are lower than the $9,800 average in the US, patients should confirm if the price includes the required follow-up ultrasound scans or if those are separate charges.
Patient Consensus: Many individuals emphasize treating this as a trial option rather than a cure. Patients suggest asking for specific protocols because results vary, especially between younger patients and those in late perimenopause.
No, PRP/PRGF ovarian rejuvenation in the Czech Republic is not guaranteed to work. It is an experimental fertility add-on. Reputable clinics in Prague offer it to potentially improve hormonal markers like AMH, but ethical standards prohibit doctors from guaranteeing a pregnancy or biological reversal of ovarian aging.
Bookimed Expert Insight: While Czech clinics like MY CLINIC maintain high SAK accreditation standards, patients should not view the $2,800 entry cost as a fixed solution. Data shows this procedure is often a final investigative step before moving to donor egg programs. Clinics with direct university partnerships often provide more realistic counseling than those focusing heavily on clinical marketing. Always ask for live-birth data specifically rather than internal egg retrieval metrics.
Patient Consensus: Clinical marketing sometimes inflates potential benefits, yet many patients report no meaningful change after treatment. The procedure feels like a gamble to improve odds rather than a reliable fertility replacement.
Ideal candidates for ovarian rejuvenation in the Czech Republic include women under 44 with diminished ovarian reserve or premature ovarian insufficiency. This experimental procedure targets patients seeking to activate dormant follicles after poor IVF responses or those in early perimenopause wanting to improve antral follicle counts.
Bookimed Expert Insight: While Prague clinics like MY CLINIC offer advanced gynecology, ovarian rejuvenation remains an experimental approach. Data shows it serves best as a bridge to a final IVF cycle. Most clinics achieve better results when patients maintain some follicular activity rather than total ovarian failure.
Patient Consensus: Many view this as a last-resort gamble and suggest prioritizing counseling for donor egg alternatives. Real success is often measured by the production of any usable follicles rather than a guaranteed pregnancy.
PRP or PRGF ovarian rejuvenation in the Czech Republic involves injecting concentrated growth factors directly into the ovarian cortex. Performed by specialists in JCI or SAK-accredited facilities, this ultrasound-guided procedure aims to activate dormant follicles in patients with diminished ovarian reserve or premature insufficiency.
Bookimed Expert Insight: Czech fertility centers like MY CLINIC often use proprietary PRGF systems rather than standard PRP. Data shows patients save about 64% compared to US costs of $9,800. Always ask for internal success data. Many clinics bundle this with IVF, which can be more cost-effective than standalone sessions.
Patient Consensus: Most patients pursue this after poor responses to standard IVF. They advise clarifying if the clinic uses PRP or PRGF protocols before traveling to Prague.
Czech Republic clinics provide advanced PRP and PRGF ovarian rejuvenation under strict State Institute for Drug Control oversight. Patients choose Prague and Brno for minimally invasive fertility treatments, utilizing European Union safety standards and specialists experienced in treating diminished ovarian reserve at significantly lower costs than the US.
Bookimed Expert Insight: While many seek low prices, the real value in Czechia is administrative transparency. Clinics like MY CLINIC in Prague partner with Charles University and accept direct billing from Aetna or Allianz. This reduces out-of-pocket stress for international patients managing complex fertility timelines.
Patient Consensus: Patients value the structured treatment pathways and common use of free initial online consultations. Most advise coordinating diagnostics remotely to minimize travel time for this experimental-adjacent procedure.